FDA Approves New Sunscreen Ingredient, Alcohol Guidelines Politicized Debate, NSF Laser Breakthroughs Drive Growth, Breakthrough Meningioma Study Promises Personalised Treatment, and more...
About this episode
The episode discusses recent FDA approvals, the politicization of alcohol guidelines, advancements in laser technology, and breakthroughs in cancer treatment.
(0:10): FDA Approves New Sunscreen Ingredient BEMT, First in Over Two Decades (2:04): Alcohol Study Sparks Debate: Are Moderate Drinking Guidelines Influenced by Politics and Industry? (4:34): NSF Laser Innovations: From Medical Breakthroughs to Quantum Research and Economic Growth (6:38): Breakthrough Meningioma Study Reveals Tumor Microenvironment as Key to Personalized Treatment and Prognosis (8:22): Daraxonrasib Doubles Survival in Metastatic Pancreatic Cancer: A Breakthrough in KRAS Mutation Therapy To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: WSOC TV
Topics covered
- sunscreen approval
- alcohol guidelines
- laser innovations
- meningioma study
- pancreatic cancer treatment
Keywords
- FDA
- sunscreen
- alcohol guidelines
- NSF
- laser breakthroughs
- meningioma
- Daraxonrasib
- pancreatic cancer
Mentioned in this episode
Organizations: FDA, NSF, WSOC TV, brief.news
Products: BEMT, Daraxonrasib
More episodes of Science News Daily
- Whale Graveyard Unearthed, China’s JUNO Breaks Neutrino Record, ACOG Breaks Ranks on 2026 Vaccine Schedule, Arctic Icebergs Reshape Seafloor, and more...
- Survodutide Reduces Liver Fat, Fruit Fly Brain Maps Network, Octopus Arm Transforms Underwater Work, CRISPR Targets Mutant p53, and more...
- Artemis Faces Micrometeoroid Threats, Indigenous Fire Management Protects Cerrado, Survodutide Reduces Liver Fat, Genetic Resistance to GLP-1 Drugs, and more...
Explore listener stats, chart rankings, contacts and more on the Science News Daily podcast page.